Original Article
Molecular Psychiatry (2008) 13, 147–161; doi:10.1038/sj.mp.4002011; published online 1 May 2007
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia
T Hashimoto1, D Arion1, T Unger1, J G Maldonado-Avilés2, H M Morris2, D W Volk1, K Mirnics1,3 and D A Lewis1,2
- 1Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, USA
- 2Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA
- 3Department of Psychiatry and Vanderbilt Kennedy Center for Human Development Vanderbilt University, Nashville, TN, USA
Correspondence: Dr DA Lewis, Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, 3811 O'Hara St, W1650 BST, Pittsburgh, PA 15213, USA. E-mail: lewisda@upmc.edu
Received 11 December 2006; Revised 7 March 2007; Accepted 19 March 2007; Published online 1 May 2007.
Abstract
In subjects with schizophrenia, impairments in working memory are associated with dysfunction of the dorsolateral prefrontal cortex (DLPFC). This dysfunction appears to be due, at least in part, to abnormalities in
-aminobutyric acid (GABA)-mediated inhibitory circuitry. To test the hypothesis that altered GABA-mediated circuitry in the DLPFC of subjects with schizophrenia reflects expression changes of genes that encode selective presynaptic and postsynaptic components of GABA neurotransmission, we conducted a systematic expression analysis of GABA-related transcripts in the DLPFC of 14 pairs of schizophrenia and age-, sex- and post-mortem interval-matched control subjects using a customized DNA microarray with enhanced sensitivity and specificity. Subjects with schizophrenia exhibited expression deficits in GABA-related transcripts encoding (1) presynaptic regulators of GABA neurotransmission (67 kDa isoform of glutamic acid decarboxylase (GAD67) and GABA transporter 1), (2) neuropeptides (somatostatin (SST), neuropeptide Y (NPY) and cholecystokinin (CCK)) and (3) GABAA receptor subunits (
1,
4,
3,
2 and
). Real-time qPCR and/or in situ hybridization confirmed the deficits for six representative transcripts tested in the same pairs and in an extended cohort, respectively. In contrast, GAD67, SST and
1 subunit mRNA levels, as assessed by in situ hybridization, were not altered in the DLPFC of monkeys chronically exposed to antipsychotic medications. These findings suggest that schizophrenia is associated with alterations in inhibitory inputs from SST/NPY-containing and CCK-containing subpopulations of GABA neurons and in the signaling via certain GABAA receptors that mediate synaptic (phasic) or extrasynaptic (tonic) inhibition. In concert with previous findings, these data suggest that working memory dysfunction in schizophrenia is mediated by altered GABA neurotransmission in certain DLPFC microcircuits.
Keywords:
microarray, quantitative PCR, in situ hybridization, GAD, neuropeptides, GABAA receptor
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Pathophysiologically based treatment interventions in schizophrenia
Nature Medicine Review (01 Sep 2006)
NEWS AND VIEWS
Neurogenic control of the cerebral microcirculation: is dopamine minding the store?
Nature Neuroscience News and Views (01 Aug 1998)
RESEARCH
Stress-induced changes in primate prefrontal profiles of gene expression
Molecular Psychiatry Original Article
Tiagabine Increases [ 11 C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
